Drosophila melanogaster as a model organism to study Chlamydia trachomatis early effectors

Information

  • Research Project
  • 10115601
  • ApplicationId
    10115601
  • Core Project Number
    R21AI148999
  • Full Project Number
    5R21AI148999-02
  • Serial Number
    148999
  • FOA Number
    PA-19-053
  • Sub Project Id
  • Project Start Date
    3/1/2020 - 5 years ago
  • Project End Date
    2/28/2022 - 3 years ago
  • Program Officer Name
    VINCENT, LEAH REBECCA
  • Budget Start Date
    3/1/2021 - 4 years ago
  • Budget End Date
    2/28/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    2/2/2021 - 4 years ago

Drosophila melanogaster as a model organism to study Chlamydia trachomatis early effectors

SUMMARY: We aim to learn how Chlamydia trachomatis secreted effectors direct cellular changes both individually and cooperatively within fruit flies (Drosophila melanogaster). Our preliminary data indicate that expression of chlamydial Tarp in flies leads to both macroscopic (curled bristles) and microscopic (irregular microvilli) developmental defects. The fruit fly model organism contains well defined polarized cells and developmental programs which can be quantitatively evaluated. This level of precision in a polarized cell model allows for the molecular dissection of individual C. trachomatis effectors and assessment of effector cooperation which has not yet been investigated. Known targets of the early C. trachomatis effectors such as actin, Crk adapters, Src tyrosine kinases, and PI3K are conserved in the fruit fly model suggesting cellular changes observed in flies are likely to mimic the effects on human tissues. In the short term, we believe that the fruit fly model will provide mechanistic insight into chlamydial effector directed host pathogen interactions and in the long term may serve as a powerful platform to explore bacterial genes of unknown function. Elucidation of the molecular mechanisms employed by C. trachomatis to initiate a successful infection may provide clues that can be applied to novel therapeutic interventions for this prolific pathogen.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R21
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    125000
  • Indirect Cost Amount
    61250
  • Total Cost
    186250
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIAID:186250\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF CENTRAL FLORIDA
  • Organization Department
    OTHER BASIC SCIENCES
  • Organization DUNS
    150805653
  • Organization City
    ORLANDO
  • Organization State
    FL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    328263231
  • Organization District
    UNITED STATES